RxDoctor Payments Data

Lisa Proctor, APRN

Family · Groveton, TXNPI 1508521584

Payments from drug & device makers

$1,234in general payments, 2019–2025

Across 62 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$418
  • AbbVie$160
  • Mylan Specialty L.p.$134
  • AstraZeneca$126
  • Novo Nordisk$106
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$63
  • plus $227 from 8 others

What the payments were for

  • Food & beverage$1,234100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,234 in reported general payments places this provider in the 70th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Medicare billing

Part B allowed, 2024
$1,856
Medicare patients
54
Services billed
82

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide55$57,522
MounjaroTirzepatide19$19,358
EliquisApixaban16$17,510
FarxigaDapagliflozin Propanediol14$15,915
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$11,612
JanuviaSitagliptin Phosphate16$9,070
Lantus SolostarInsulin Glargine,hum.Rec.Anlog39$8,855
Tresiba Flextouch U-200Insulin Degludec11$6,531
Gabapentin127$2,267
Albuterol Sulfate HfaAlbuterol Sulfate80$1,825
Novolog FlexpenInsulin Aspart15$1,388
Scopolamine15$1,213
Omeprazole57$1,150
Pregabalin33$978
Rosuvastatin Calcium63$948

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$106$57,52255 claims
Lilly USA, LLCMounjaro$21$19,35819 claims
PfizerEliquis$38$17,51016 claims
AstraZenecaFarxiga$126$15,91514 claims
GSKTrelegy Ellipta$418$11,61218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 15,456 family providers in Texas.

Other family in Groveton

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →